Cardium Therapeutics, Inc. (CXM) Swings to Q4 Loss
Tweet
Share
E-mailGet Alerts CXM Hot Sheet
Price: $7.03 +4.30%
Financial Fact:
Research and development: 108.67K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development: 108.67K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cardium Therapeutics, Inc. (AMEX: CXM) reported Q4 EPS of ($0.02), versus $0.01 reported last year.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
